Emini; Emilio A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Emini; Emilio A..The latest application filed is for "hepatitis c virus vaccine".

Company Profile

0.6.17

Emini; Emilio A. - Wayne PA
Emini; Emilio A. - Dresher PA
Emini, Emilio A - Wayne PA
Emini; Emilio A. - Strafford PA
Emini; Emilio A. - Paoli PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Hepatitis C virus vaccine Grant 8,142,794 - Emini , et al. March 27, 2	2012-03-27
Hepatitis C virus vaccine Grant 7,598,362 - Emini , et al. October 6, 2	2009-10-06
Hepatitis C Virus Vaccine App 20090233992 - Emini; Emilio A. ; et al.	2009-09-17
Adenovirus Serotype 26 Vectors, Nucleic Acid and Viruses Produced Thereby App 20080254059 - Bett; Andrew J. ; et al.	2008-10-16
Adenoviral Vector Compositions App 20080063656 - Emini; Emilio A. ; et al.	2008-03-13
Enhanced first generation adenovirus vaccines expressing condon optimized HIV1-Gag, Pol, Nef and modifications App 20070077257 - Emini; Emilio A. ; et al.	2007-04-05
Enhanced first generation adenovirus vaccines expressing codon optimized HIV1-Gag, Pol, Nef and modifications App 20070054395 - Emini; Emilio A. ; et al.	2007-03-08
Therapeutic immunization of hiv-infected individuals App 20060216272 - Emini; Emilio A. ; et al.	2006-09-28
Method of inducing an enhanced immune response against hiv App 20060165664 - Emini; Emilio A. ; et al.	2006-07-27
Method of inducing an enhanced immune response against hiv App 20050106123 - Emini, Emilio A ; et al.	2005-05-19
Enhanced first generation adenovirus vaccines expressing codon optimized HIV1-Gag, Pol, Nef and modifications App 20050070017 - Emini, Emilio A. ; et al.	2005-03-31
Hepatitis c virus vaccine App 20040247615 - Emini, Emilio A ; et al.	2004-12-09
Adenovirus serotype 34 vectors, nucleic acids and virus produced thereby App 20040191222 - Emini, Emilio A. ; et al.	2004-09-30
Adenovirus serotype 24 vectors, nucleic acids and virus produced thereby App 20040185555 - Emini, Emilio A. ; et al.	2004-09-23
Adenovirus carrying gag gene HIV vaccine Grant 6,787,351 - Chen , et al. September 7, 2	2004-09-07
Methods for propagating adenovirus and virus produced thereby App 20040106194 - Bett, Andrew J. ; et al.	2004-06-03
Enhanced first generation adenovirus vaccines expressing codon optimized hiv1-gag, pol.nef and modifications App 20040101957 - Emini, Emilio A. ; et al.	2004-05-27
Enhanced first generation adenovirus vaccines expressing codon optimized HIV1-gag, pol, nef and modifications Grant 6,733,993 - Emini , et al. May 11, 2	2004-05-11
Combination therapy for HIV infection Grant 6,689,761 - Chodakewitz , et al. February 10, 2	2004-02-10
Adenovirus carrying gag gene HIV vaccine App 20030228329 - Chen, Ling ; et al.	2003-12-11
Enhanced first generation adenovirus vaccines expressing codon optimized HIV1-Gag, Pol, Nef and modifications App 20030044421 - Emini, Emilio A. ; et al.	2003-03-06
Adenovirus carrying gag gene HIV vaccine App 20020061517 - Chen, Ling ; et al.	2002-05-23
Immunogenic HAV peptides Grant 4,596,674 - Emini , et al. June 24, 1	1986-06-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.